@juxtaposer You do know that Starpharma or a partner are at least 4 years away from even submitting a new drug application (NDA) ? And that is dependent on ‘somebody’ conducting a successful Phase 3 trial which could possibly commence next year if DEP is licenced or alternatively SPL conduct a huge capital raising.
Priority and Breakthrough Drugs -FDA, page-2
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
